Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM

NCT02555007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer (NSCLC)
Malignant Pleural Mesothelioma (MPM)

Interventions

DRUG: Vinorelbine

Sponsor

Assistance Publique Hopitaux De Marseille